FDA Inspection
Hubei Gedian Humanwell Pharmaceutical Co., Ltd.Hubei Gedian Humanwell Pharmaceutical Co., Ltd. – FDA Inspection, Nov 7, 2025
Record Details
This FDA Inspection record concerns Hubei Gedian Humanwell Pharmaceutical Co., Ltd., with an inspection on November 7, 2025, covering drugs.
- Inspection Date
- November 7, 2025
- Product Type
- Drugs
View Company Profile
ID · c10af8d3-b0c2-4c42-8499-ae577c9698b7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1295344
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
- FDA Inspection 1098272 - 2019-06-28
- FDA Inspection 971471 - 2016-05-13
- FDA Inspection 854699 - 2013-10-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.